186 related articles for article (PubMed ID: 25916906)
1. Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2.
Kaserer T; Temml V; Kutil Z; Vanek T; Landa P; Schuster D
Eur J Med Chem; 2015; 96():445-57. PubMed ID: 25916906
[TBL] [Abstract][Full Text] [Related]
2. Pharmacophore modeling for COX-1 and -2 inhibitors with LigandScout in comparison to Discovery Studio.
Temml V; Kaserer T; Kutil Z; Landa P; Vanek T; Schuster D
Future Med Chem; 2014; 6(17):1869-81. PubMed ID: 25495981
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of new 4-phenylpyrimidine-2(1H)-thiones and their potency to inhibit COX-1 and COX-2.
Seebacher W; Faist J; Presser A; Weis R; Saf R; Kaserer T; Temml V; Schuster D; Ortmann S; Otto N; Bauer R
Eur J Med Chem; 2015 Aug; 101():552-9. PubMed ID: 26197159
[TBL] [Abstract][Full Text] [Related]
4. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example.
Rollinger JM; Haupt S; Stuppner H; Langer T
J Chem Inf Comput Sci; 2004; 44(2):480-8. PubMed ID: 15032527
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
[TBL] [Abstract][Full Text] [Related]
7. Discovering COX-inhibiting constituents of Morus root bark: activity-guided versus computer-aided methods.
Rollinger JM; Bodensieck A; Seger C; Ellmerer EP; Bauer R; Langer T; Stuppner H
Planta Med; 2005 May; 71(5):399-405. PubMed ID: 15931575
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.
Chen CS; Tan CM; Huang CH; Chang LC; Wang JP; Cheng FC; Chern JW
Bioorg Med Chem; 2010 Jan; 18(2):597-604. PubMed ID: 20056549
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG
Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of selected 3D virtual screening tools for the prospective identification of peroxisome proliferator-activated receptor (PPAR) γ partial agonists.
Kaserer T; Obermoser V; Weninger A; Gust R; Schuster D
Eur J Med Chem; 2016 Nov; 124():49-62. PubMed ID: 27560282
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel pyrazole and pyrazolo[1,5-a]pyrimidine derivatives as cyclooxygenase inhibitors (COX-1 and COX-2) using molecular modeling simulation.
Ayman R; Radwan AM; Elmetwally AM; Ammar YA; Ragab A
Arch Pharm (Weinheim); 2023 Feb; 356(2):e2200395. PubMed ID: 36336646
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potential and selective COX-1 inhibitory leads using pharmacophore modelling, in silico screening and in vitro evaluation.
Balaji B; Hariharan S; Shah DB; Ramanathan M
Eur J Med Chem; 2014 Oct; 86():469-80. PubMed ID: 25203777
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R
Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552
[TBL] [Abstract][Full Text] [Related]
14. In vitro COX-1 and COX-2 enzyme inhibitory activities of iridoids from Penstemon barbatus, Castilleja tenuiflora, Cresentia alata and Vitex mollis.
Ramírez-Cisneros MÁ; Rios MY; Aguilar-Guadarrama AB; Rao PP; Aburto-Amar R; Rodríguez-López V
Bioorg Med Chem Lett; 2015 Oct; 25(20):4505-8. PubMed ID: 26351040
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
Abdel-Aziz AA; ElTahir KE; Asiri YA
Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719
[TBL] [Abstract][Full Text] [Related]
16. Indole based cyclooxygenase inhibitors: synthesis, biological evaluation, docking and NMR screening.
Estevão MS; Carvalho LC; Freitas M; Gomes A; Viegas A; Manso J; Erhardt S; Fernandes E; Cabrita EJ; Marques MM
Eur J Med Chem; 2012 Aug; 54():823-33. PubMed ID: 22796043
[TBL] [Abstract][Full Text] [Related]
17. Spherical harmonics coefficients for ligand-based virtual screening of cyclooxygenase inhibitors.
Wang Q; Birod K; Angioni C; Grösch S; Geppert T; Schneider P; Rupp M; Schneider G
PLoS One; 2011; 6(7):e21554. PubMed ID: 21818259
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation as well as in silico studies of arylpiperazine-1,2-benzothiazine derivatives as novel anti-inflammatory agents.
Szczęśniak-Sięga BM; Wiatrak B; Czyżnikowska Ż; Janczak J; Wiglusz RJ; Maniewska J
Bioorg Chem; 2021 Jan; 106():104476. PubMed ID: 33250206
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of linear phenylethynylbenzenesulfonamide regioisomers as cyclooxygenase-1/-2 (COX-1/-2) inhibitors.
Anana R; Rao PN; Chen QH; Knaus EE
Bioorg Med Chem; 2006 Aug; 14(15):5259-65. PubMed ID: 16635574
[TBL] [Abstract][Full Text] [Related]
20. COX-1/COX-2 inhibition activities and molecular docking study of newly designed and synthesized pyrrolo[3,4-c]pyrrole Mannich bases.
Redzicka A; Szczukowski Ł; Kochel A; Wiatrak B; Gębczak K; Czyżnikowska Ż
Bioorg Med Chem; 2019 Sep; 27(17):3918-3928. PubMed ID: 31345747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
